Patents by Inventor Keith Peek

Keith Peek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Component of bromelain
    Patent number: 9663777
    Abstract: The invention relates to a component of bromelain which is largely responsible for the ability of bromelain to interrupt the MAP kinase cascade. The component contains ananain and comosain and is useful in the treatment or prevention of diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway.
    Type: Grant
    Filed: October 12, 2010
    Date of Patent: May 30, 2017
    Assignee: Sarantis Pty Ltd
    Inventors: Tracey Lehanne Mynott, Christian Engwerda, Keith Peek
  • Secreted proteins
    Patent number: 8101187
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: January 24, 2012
    Assignee: Sanofi Pasteur Limited
    Inventors: Richard William Falla Le Page, Daniel Badcock, Philip James Holden Sizer, Keith Peek, Jeremy Mark Wells, Sean Bosco Hanniffy
  • COMPONENT OF BROMELAIN
    Publication number: 20110027259
    Abstract: The invention relates to a component of bromelain which is largely responsible for the ability of bromelain to interrupt the MAP kinase cascade. The component contains ananain and comosain and is useful in the treatment or prevention of diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway.
    Type: Application
    Filed: October 12, 2010
    Publication date: February 3, 2011
    Applicant: SARANTIS PTY LTD
    Inventors: Tracey Lehanne MYNOTT, Christian ENGWERDA, Keith PEEK
  • Component of bromelain
    Patent number: 7833963
    Abstract: The invention relates to a component of bromelain which is largely responsible for the ability of bromelain to interrupt the MAP kinase cascade. The component contains ananain and comosain and is useful in the treatment or prevention of diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: November 16, 2010
    Assignee: Sarantis Pty Ltd
    Inventors: Tracey L. Mynott, Christian Engwerda, Keith Peek
  • Secreted Streptococcus Pneumoniae Proteins
    Publication number: 20090074808
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Application
    Filed: July 28, 2008
    Publication date: March 19, 2009
    Inventors: Richard William Falla Le Page, Daniel Badcock, Philip James Holden Sizer, Keith Peek, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Proteins
    Publication number: 20040265933
    Abstract: Novel proteins from Streptococcus pneumoniae are described, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Application
    Filed: August 30, 2004
    Publication date: December 30, 2004
    Inventors: Richard William Falla Le Page, Daniel Badcock, Philip James Holden Sizer, Keith Peek, Jeremy Mark Wells, Sean Bosco Hanniffy
  • Component of bromelain
    Publication number: 20040057948
    Abstract: The invention relates to a component of bromelain which is largely responsible for the ability of bromelain to interrupt the MAP kinase cascade. The component contains ananain and comosain and is useful in the treatment or prevention of diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway.
    Type: Application
    Filed: June 3, 2003
    Publication date: March 25, 2004
    Inventors: Tracey Lehanne Mynott, Christian Engwerda, Keith Peek
  • Component of stem bromelain
    Publication number: 20020188107
    Abstract: A novel protein is a component of stem bromelain and is an anti-cancer agent, an immunostimulant and has antimicrobial activity. The protein may be isolated from stem bromelain by methods such as HPLC.
    Type: Application
    Filed: December 28, 2001
    Publication date: December 12, 2002
    Applicant: Provalis UK Limited
    Inventors: Tracey Lehanne Mynott, Christian Engwerda, Keith Peek
  • Component of bromelain
    Publication number: 20020102253
    Abstract: The invention relates to a component of bromelain which is largely responsible for the ability of bromelain to interrupt the MAP kinase cascade. The component contains ananain and comosain and is useful in the treatment or prevention of diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway.
    Type: Application
    Filed: December 29, 2000
    Publication date: August 1, 2002
    Inventors: Tracey Lehanne Mynott, Christian Engwerda, Keith Peek
  • Component of stem bromelain
    Patent number: 6335427
    Abstract: A novel protein is a component of stem bromelain and is an anti-cancer agent, an immunostimulant and has antimicrobial activity. The protein may be isolated from stem bromelain by methods such as HPLC and has a molecular weight of about 25.08 kDa and an isoelectric point of about 3.8 or 3.85.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: January 1, 2002
    Assignee: Provalis UK Limited
    Inventors: Tracey Lehanne Mynott, Christian Engwerda, Keith Peek